OAS1 rs1077822: Understanding Your Genetic Variant
The rs1077822 variant is a genetic change located within the OAS1 gene, which plays a critical role in the body's innate immune response to viral infections. This variant is associated with differences in how the OAS1 gene is spliced, potentially influencing how effectively the body detects and responds to certain respiratory viruses.
What each genotype means
Lower active enzyme production
Carrying two copies of the A allele predominantly directs splicing of the OAS1 gene toward shorter isoforms, such as p42, rather than the enzymatically more active p46 isoform. In observational and association studies, this genotype has been linked with an increased susceptibility to severe viral respiratory infections, including SARS-CoV-2. However, clinical outcomes are multifactorial, and genetic predisposition reflects only a modest statistical change in relative risk rather than a definitive health outcome.
Carried by approximately 40% to 45% of individuals of European ancestry and roughly 15% to 20% of individuals of East Asian ancestry.
Intermediate active enzyme production
Having one A allele and one G allele produces balanced expression of both alternative OAS1 transcripts, generating both the p42 isoform and the enzymatically active p46 isoform. Population studies indicate that heterozygous individuals exhibit an intermediate risk profile for severe respiratory viral illness relative to homozygous genotypes. This association represents a statistical predisposition within populations and does not diagnose disease or dictate individual clinical care.
Found in approximately 45% to 50% of people across most global populations, including European and East Asian ancestries.
Higher active enzyme production
Carrying two copies of the G allele ensures efficient splicing that generates the full-length, prenylated p46 isoform of the OAS1 enzyme with higher antiviral catalytic activity. In published epidemiological cohorts, this genotype is statistically correlated with relative protection against severe courses of certain viral respiratory infections. Because health outcomes depend heavily on clinical, environmental, and immunological factors, carrying this genotype does not confer complete immunity against infection.
Carried by approximately 10% to 15% of individuals of European ancestry and roughly 35% to 40% of individuals of East Asian ancestry.
What is rs1077822?
The rs1077822 variant is a single nucleotide polymorphism (SNP) located within the OAS1 gene. SNPs are the most common type of genetic variation in humans, representing a difference in a single "letter" of the DNA code. This specific variant is situated at a splice-acceptor site, a critical junction that tells the cellular machinery where to cut and join segments of RNA during the process of gene expression. By altering this site, the variant can change the final structure of the OAS1 protein produced by the cell. Because this gene is essential for the immune system's ability to sense viral genetic material, variations here are of significant interest to researchers studying how different people respond to infections.
The Role of the OAS1 Gene
The OAS1 gene encodes an enzyme called 2'-5'-oligoadenylate synthetase 1. This enzyme is a key component of the innate immune system, which acts as the body's first line of defense against pathogens. When a cell detects the presence of viral RNA, OAS1 is activated and produces molecules that trigger a secondary enzyme, RNase L. Once activated, RNase L degrades both viral and cellular RNA, effectively halting the virus's ability to replicate and spread within the body. Because this pathway is so fundamental to antiviral defense, any genetic variation that alters the expression or activity of the OAS1 enzyme can theoretically impact an individual's susceptibility to various viral respiratory infections.
Research and Evidence
Research into rs1077822 and related OAS1 variants has primarily focused on their role in modulating immune responses to viral threats, including SARS-CoV-2. Studies suggest that the variant influences the production of different OAS1 protein isoforms, which vary in their enzymatic activity. While some research indicates that certain alleles are associated with altered susceptibility to severe viral outcomes, the evidence remains limited and complex. It is important to note that genetic associations are statistical in nature and do not guarantee a specific health outcome. Many factors, including age, underlying health conditions, and environmental exposures, play a much larger role in determining how an individual responds to a viral infection than any single genetic variant.
Population Frequency
The frequency of the rs1077822 variant varies significantly across different global populations. Data indicates that the alternative allele frequency is approximately 0.35 in European populations and rises to approximately 0.60 in East Asian populations. These differences highlight the importance of considering ancestry when interpreting genetic data, as the prevalence of specific genotypes can differ widely depending on one's genetic background.
What This Means for You
Understanding your genotype for rs1077822 provides insight into your genetic makeup but does not serve as a medical diagnosis or a predictor of your personal health. Because the evidence linking this variant to specific clinical outcomes is limited, it should not be used to make decisions about your health or medical care. If you have concerns about your immune health or susceptibility to infections, the best course of action is to consult with a qualified healthcare professional. They can provide guidance based on your complete medical history and current clinical guidelines, rather than relying on isolated genetic information.
How common is this variant?
The alternative allele frequency for rs1077822 is approximately 0.35 in European populations and approximately 0.60 in East Asian populations.
Frequently asked questions
Does having the 'risk' allele mean I will get sick?
No. Genetic associations are statistical trends observed in large groups of people and do not predict individual health outcomes. Many factors, such as your environment and overall health, are far more important than a single genetic variant.
Can I use this information to change my medication?
No. You should never change your medication or dosing based on genetic test results without consulting your doctor or pharmacist. Always discuss your genetic information with a healthcare professional before making any medical decisions.
Is rs1077822 the same as other OAS1 variants?
While rs1077822 is located in the same gene as other well-studied variants like rs10774671, they are distinct markers. Each variant may have different effects on gene expression and clinical associations.
Where can I find more information about my specific genotype?
You can look up your specific rsID on databases like the NCBI SNP database or ClinVar. However, these resources are technical, and it is best to discuss any findings with a genetic counselor or your primary care physician.
Sources & further reading
Educational information only, last refreshed 10/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1077822?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in OAS1
Splice-site variant in OAS1 affecting isoform expression and susceptibility to viral infections.
This splice-acceptor variant regulates alternative splicing of OAS1, modulating enzymatic activity and host susceptibility to viral infections.